Publication:
Role of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study.

dc.contributor.authorCoronado, Pluvio J
dc.contributor.authorRychlik, Agnieszka
dc.contributor.authorMartínez-Maestre, Maria A
dc.contributor.authorBaquedano, Laura
dc.contributor.authorFasero, María
dc.contributor.authorGarcía-Arreza, Aida
dc.contributor.authorMorales, Sara
dc.contributor.authorLubian, Daniel M
dc.contributor.authorZapardiel, Ignacio
dc.date.accessioned2023-01-25T10:01:40Z
dc.date.available2023-01-25T10:01:40Z
dc.date.issued2018
dc.description.abstractTo assess the impact of lymph node dissection (LND) on morbidity, survival, and cost for intermediate-risk endometrial cancers (IREC). A multicenter retrospective cohort of 720 women with IREC (endometrioid histology with myometrial invasion Both study groups were homogeneous in demographic data and pathologic results. The mean follow-up in patients free of disease was 61.7 months (range, 12.0-275.5). DFS (hazard ratio [HR]=1.34; 95% confidence interval [CI]=0.79-2.28) and OS (HR=0.72; 95% CI=0.42-1.23) were similar in both groups, independently of nodes count. In LND group, positive nodes were found in 10 cases (5.6%). Operating time and late postoperative complications were higher in LND group (p Systematic LND in IREC has no benefit on survival, although it does not show an increase in perioperative morbidity or global cost.
dc.identifier.doi10.3802/jgo.2018.29.e1
dc.identifier.essn2005-0399
dc.identifier.pmcPMC5709519
dc.identifier.pmid29185259
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709519/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.3802/jgo.2018.29.e1
dc.identifier.urihttp://hdl.handle.net/10668/11853
dc.issue.number1
dc.journal.titleJournal of gynecologic oncology
dc.journal.titleabbreviationJ Gynecol Oncol
dc.language.isoen
dc.organizationHospital Universitario de Puerto Real
dc.organizationHospital Universitario Virgen del Rocío
dc.page.numbere1
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.subjectCosts and Cost Analysis
dc.subjectEndometrial Neoplasms
dc.subjectLymph Node Excision
dc.subjectMorbidity
dc.subjectRisk Factors
dc.subjectSurvival
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshCost-Benefit Analysis
dc.subject.meshEndometrial Neoplasms
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshLymph Node Excision
dc.subject.meshLymphatic Metastasis
dc.subject.meshMatched-Pair Analysis
dc.subject.meshMiddle Aged
dc.subject.meshMorbidity
dc.subject.meshNeoplasm Staging
dc.subject.meshPostoperative Complications
dc.subject.meshRetrospective Studies
dc.subject.meshRisk Factors
dc.subject.meshSeverity of Illness Index
dc.subject.meshSurvival Analysis
dc.subject.meshTreatment Outcome
dc.subject.meshUterine Neoplasms
dc.titleRole of lymphadenectomy in intermediate-risk endometrial cancer: a matched-pair study.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number29
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC5709519.pdf
Size:
712.87 KB
Format:
Adobe Portable Document Format